Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Nanoparticles Promise New Methods To Boost Oncology Outcomes In Breast Cancer.

J. Islamian, Milad Hatamian, M. Rashidi
Published 2015 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Different types of treatment are available for patients with breast cancer, the most being radiotherapy, chemotherapy, hormonal therapy and combination therapy. Recently, nanoparticles have been emerging as promising agents for cancer therapy and are being investigated as contrast agents, drug carriers, radiosensitizers and also for hyperthermia effects. In this review the focus is on approaches for targeted treatment of breast cancer by combining nanoparticles, chemodrugs and radiation. The availble data suggest the possibility of increased roles for combined therapy, particularly by reducing the dose of each treatment modality, and consequently minimizing related side effects.
This paper references
10.4081/JNAI.2010.E11
Molecular markers for prediction of risk of radiation-related injury to normal tissue
M. Ghilotti (2010)
10.1016/j.ijrobp.2010.08.044
Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies.
S. Jain (2011)
10.7314/APJCP.2014.15.10.4311
Cytotoxic activity of biosynthesized gold nanoparticles with an extract of the red seaweed Corallina officinalis on the MCF-7 human breast cancer cell line.
H. El-Kassas (2014)
10.1007/978-1-4613-4349-3_10
Adriamycin Metabolism in Man
N. Bachur (1976)
10.7150/thno.4827
Multifunctional Iron Oxide Nanoparticles for Diagnostics, Therapy and Macromolecule Delivery
S. K. Yen (2013)
10.1126/SCIENCE.123.3191.309
[Origin of cancer cells].
O. Warburg (1956)
10.7314/APJCP.2012.13.4.1617
Gold nanoparticles induce apoptosis in MCF-7 human breast cancer cells.
Manar E. Selim (2012)
10.1007/s11307-010-0299-8
AuNP-DG: Deoxyglucose-Labeled Gold Nanoparticles as X-ray Computed Tomography Contrast Agents for Cancer Imaging
B. Aydogan (2010)
10.3923/JBS.2008.380.385
p53 expression in MCF7, T47D and MDA-MB 468 breast cancer cell lines treated with adriamycin using RT-PCR and immunocytochemistry
S. Kaabinejadian (2008)
10.1016/S0360-3016(01)01534-6
Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
B. S. Dwarkanath (2001)
10.7314/APJCP.2014.15.12.4739
Nanoparticle induced oxidative stress in cancer cells: adding new pieces to an incomplete jigsaw puzzle.
D. Nogueira (2014)
10.4048/jbc.2012.15.2.141
Enhanced Radiosensitivity and Chemosensitivity of Breast Cancer Cells by 2-Deoxy-D-Glucose in Combination Therapy
F. Aghaee (2012)
10.1136/bmj.321.7261.624
Breast cancer—epidemiology, risk factors, and genetics
K. McPherson (2000)
10.4048/jbc.2013.16.2.164
Enhancing the Effects of Low Dose Doxorubicin Treatment by the Radiation in T47D and SKBR3 Breast Cancer Cells
F. Aghaee (2013)
10.1007/s10549-007-9671-z
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
W. Yang (2007)
10.1097/RLI.0b013e3181e6f42f
Optimal Enhancement Configuration of Silica Nanoparticles for Ultrasound Imaging and Automatic Detection at Conventional Diagnostic Frequencies
S. Casciaro (2010)
10.2147/IJN.S28344
Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model
Matthew T. Basel (2012)
10.1016/S1470-2045(02)00818-5
Hyperthermia in combined treatment of cancer.
P. Wust (2002)
10.1667/RR1080.1
Radiosensitization of DNA by Gold Nanoparticles Irradiated with High-Energy Electrons
Y. Zheng (2008)
10.1016/S0300-483X(02)00383-9
Antioxidant nutrients and adriamycin toxicity.
J. Quiles (2002)
10.1038/231064b0
Metabolism and Cancer
S. Shall (1971)
10.2478/s11535-010-0060-y
2DG enhances the susceptibility of breast cancer cells to doxorubicin
I. Ahmad (2010)
10.7314/APJCP.2013.14.1.409
In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model.
H. Yin (2013)
10.7314/APJCP.2014.15.5.2335
Development of polymeric nanopaclitaxel and comparison with free paclitaxel for effects on cell proliferation of MCF-7 and B16F0 carcinoma cells.
D. Yadav (2014)
10.1186/1477-3155-11-1
Magnetic core-shell nanoparticles for drug delivery by nebulization
N. Verma (2013)
10.1259/bjr/59448833
Gold nanoparticles as novel agents for cancer therapy.
S. Jain (2012)
10.1016/j.addr.2008.08.004
Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer.
P. Juzenas (2008)
10.1016/S0306-9877(98)90036-6
Antioxidant inhibitors for cancer therapy.
Q. Kong (1998)
10.25011/CIM.V31I3.3473
Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles.
X. Zhang (2008)
10.1161/CIRCULATIONAHA.107.741181
Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis
M. Nahrendorf (2008)
10.1093/BJA/77.1.3
Mechanisms of cell injury and death.
J. Cobb (1996)
10.1186/1748-717X-3-1
Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer
J. Yuen (2008)
10.2147/IJN.S25460
Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
Yan Chen (2011)
10.1259/BJR/28250432
Gold nanoparticles: a new X-ray contrast agent.
M. Geso (2007)
10.1158/0008-5472.CAN-11-3928
Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
G. Cheng (2012)
10.1016/S1470-2045(10)70071-1
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
R. Issels (2010)
10.1016/S0168-3659(01)00342-X
Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier.
S. Mitra (2001)
10.1097/00000441-193107000-00022
THE METABOLISM OF TUMORS
Otto Warburn (1931)
10.1016/0360-3016(96)00154-X
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group.
C. Vernon (1996)
10.1002/QUA.560280725
Metabolism and cancer
A. Szent-Györgyi (2009)
10.1023/A:1016114026769
Novel Therapeutic Approach: Ligands for PPARγ and Retinoid Receptors Induce Apoptosis in bcl-2-positive Human Breast Cancer Cells
E. Elstner (2004)
Adriamycin metabolism in man. Evidence from urinary metabolites.
S. Takanashi (1976)
10.1088/0031-9155/50/15/N01
Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study.
S. Cho (2005)
10.1186/1748-717X-3-12
The effect of radio-adaptive doses on HT29 and GM637 cells
S. B. Schwarz (2008)
10.1016/j.biomaterials.2009.04.020
The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapy.
C. Hou (2009)
10.1016/j.biomaterials.2009.02.001
Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging.
J. Lu (2009)
10.1016/S0140-6736(00)02059-6
Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial
J. Zee (2000)
Awareness and practice of breast self examination among malaysian women with breast cancer.
Siew Yim Loh (2011)
Metabolism and cancer: an up-to-date review of a mutual connection.
A. Mentis (2010)



This paper is referenced by
10.7314/APJCP.2015.16.15.6347
Evaluation of Common Risk Factors for Breast Carcinoma in Females: a Hospital Based Study in Karachi, Pakistan.
S. Sufian (2015)
ssociation of Cytochrome P450-1B1 Gene Polymorphisms with Risk of Breast Cancer: an Egyptian Study.
M. Ibrahim (2016)
10.7314/APJCP.2015.16.16.7003
BIAN N-Heterocyclic Gold Carbene Complexes induced cytotoxicity in human cancer cells via upregulating oxidative stress.
M. Farooq (2015)
10.5603/NMR.a2018.0008
A study on drug delivery tracing with radiolabeled mesoporous hydroxyapatite nanoparticles conjugated with 2DG/DOX for breast tumor cells.
Mahdiyeh Shamsi (2018)
10.1016/J.JMIR.2015.10.006
Radioprotective Effects of Amifostine and Lycopene on Human Peripheral Blood Lymphocytes In Vitro.
J. Pirayesh Islamian (2016)
10.1016/j.biologicals.2016.09.005
Novel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancer.
S. Arami (2016)
10.1016/j.metabol.2015.07.005
Inhibition of tumor energy pathways for targeted esophagus cancer therapy.
A. Shafaee (2015)
10.4172/1948-5956.1000338
A Review of Two Promising Radiosensitizers in Brain Metastases: Rrx-001 and 2-Deoxyglucose
B. Oronsky (2015)
10.1002/jcp.29562
Overexpression of CFL1 in gastric cancer and the effects of its silencing by siRNA with a nanoparticle delivery system in the gastric cancer cell line.
Seyedeh Saideh Daryabari (2020)
10.20944/PREPRINTS201809.0569.V1
Chemotherapeutic Drug Functionalized Nanoparticles are Beneficial When Treating Breast Cancer Via Magnetic Hyperthermia
S. Piehler (2018)
10.1016/J.JDDST.2020.101576
Metal-based nanoparticles as radio-sensitizer in gastric cancer therapy
Sepehr Batooei (2020)
Semantic Scholar Logo Some data provided by SemanticScholar